Form 8-K · Current report
Solventum 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0001964738
- Accession no.
- 0001964738-26-000043
Summary
Solventum announced its intention to pursue a separation of its Health Information Systems business, a healthcare software unit with $1.4 billion in annual sales, as part of its portfolio optimization strategy; CEO Bryan Hanson said separation could unlock value by letting both businesses pursue distinct growth agendas. Solventum is evaluating structures including an independent company or a combination with a scaled player, targeting completion within 12 to 18 months, with no assurance a transaction will occur.
Key points
- Health Information Systems generates $1.4 billion in annual sales for the twelve months ended December 31, 2025, operates in 30+ countries and is used by more than 75% of U.S. hospitals.
- The unit processes approximately 660 million clinical documents monthly and operates in an addressable market of roughly $10 billion estimated to grow 5–6% annually.
- Any separation would be subject to Board of Directors approval, regulatory requirements and other customary conditions, and no decision has been made on ultimate structure or timing.
- Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC are acting as financial advisors and Cleary Gottlieb Steen & Hamilton LLP as legal counsel.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure On August 5, 2026, Solventum Corporation issued the press release attached hereto as Exhibit 99.1 with respect to the matters set forth in Item 8.01. The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.